| Heartland Country Village | |
| 634 Center St, Black Earth, Wisconsin 53515 | |
| (608) 767-2572 | |
| Name | Heartland Country Village |
|---|---|
| Location | 634 Center St, Black Earth, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 50 |
| Occupancy Rate | 50% |
| Medicare ID (CCN) | 525521 |
| Legal Business Name | Trousdale Foundation Inc. Benchmark Healthcare Of Dane County |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1003819616 |
| Organization Name | TROUSDALE FOUNDATION, INC BENCHMARK HEALTHCARE OF DANE COUNTY |
| Doing Business As | HEARTLAND COUNTRY VILLAGE |
| Address | 634 Center St, Black Earth, WI 53515 |
| Phone Number | 608-767-2572 |
News Archive
Health and Human Services Secretary Kathleen Sebelius confirmed Friday that the federal government would stop funding the program which provides health care to more than 100,000 women after Texas barred Planned Parenthood and other "affiliates of abortion providers" from participating. Gov. Rick Perry has pledged to replace the money, but has not said where it would come from.
As consumers begin to take greater ownership of their own healthcare, there is a growing demand for accessibility to diagnostic testing. Alverix, Inc. and BD (Becton, Dickinson and Company) are on the cutting edge of this trend and today announced an agreement to produce assay systems at the point-of-care (POC) that will improve infectious disease diagnoses.
Array BioPharma today announced that ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs).
When it comes to reducing inflammation to decrease the risk of heart disease and stroke, results from the much-anticipated Cardiovascular Inflammation Reduction Trial indicate that targeting the right inflammatory pathways in at-risk patients is crucial.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Health and Human Services Secretary Kathleen Sebelius confirmed Friday that the federal government would stop funding the program which provides health care to more than 100,000 women after Texas barred Planned Parenthood and other "affiliates of abortion providers" from participating. Gov. Rick Perry has pledged to replace the money, but has not said where it would come from.
As consumers begin to take greater ownership of their own healthcare, there is a growing demand for accessibility to diagnostic testing. Alverix, Inc. and BD (Becton, Dickinson and Company) are on the cutting edge of this trend and today announced an agreement to produce assay systems at the point-of-care (POC) that will improve infectious disease diagnoses.
Array BioPharma today announced that ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs).
When it comes to reducing inflammation to decrease the risk of heart disease and stroke, results from the much-anticipated Cardiovascular Inflammation Reduction Trial indicate that targeting the right inflammatory pathways in at-risk patients is crucial.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 23.33 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 0 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 11.76 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.57 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.05 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 36.36 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.14 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.01 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.2 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 25.57 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 2.94 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.49 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 89.76 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 91.23 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 61.64 | 82.93 |
News Archive
Health and Human Services Secretary Kathleen Sebelius confirmed Friday that the federal government would stop funding the program which provides health care to more than 100,000 women after Texas barred Planned Parenthood and other "affiliates of abortion providers" from participating. Gov. Rick Perry has pledged to replace the money, but has not said where it would come from.
As consumers begin to take greater ownership of their own healthcare, there is a growing demand for accessibility to diagnostic testing. Alverix, Inc. and BD (Becton, Dickinson and Company) are on the cutting edge of this trend and today announced an agreement to produce assay systems at the point-of-care (POC) that will improve infectious disease diagnoses.
Array BioPharma today announced that ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe knee pain despite the use of non-steroidal anti-inflammatory drugs (NSAIDs).
When it comes to reducing inflammation to decrease the risk of heart disease and stroke, results from the much-anticipated Cardiovascular Inflammation Reduction Trial indicate that targeting the right inflammatory pathways in at-risk patients is crucial.
› Verified 9 days ago